Amagree (Vamorolone)

Brand Options

arrow pointer

Brand Name : Amagree

Marketing Authorization Holder : Santhera

Prescription Required

 
 
No Generic Medicine available for this medicine.

Product Details

Amagree

Amagree is now available from Europe.

Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.

According to the European Medicines Agency, brand name Amagree originating from Europe is manufactured at the following site(s):Santhera Pharmaceuticals (Deutschland) GmbH Marie-Curie-Straße 8 D-79539 Lörrach Germany

Information about AMAGREE (vamorolone): 

AMAGREE (vamorolone) is used to reduce inflammation and modify immune responses. It is particularly employed in the management of Duchenne muscular dystrophy (DMD), a genetic disorder characterized by progressive muscle degeneration and weakness. 

Vamorolone functions similarly to corticosteroids but with potentially fewer side effects, making it a promising alternative in managing DMD symptoms.

Product Highlights

  • AMAGREE (vamorolone) stands out due to its novel mechanism of action compared to traditional corticosteroids. 
  • It acts as a selective glucocorticoid receptor agonist, which means it targets specific receptors involved in inflammation without fully activating them.
  • Potentially reducing adverse effects commonly associated with traditional steroids.
  • AMAGREE (vamorolone) in patients 2 years of age and older.

Key Ingredients

  • Vamorolone
  • Citric acid(monohydrate), 
  • Disodium phosphate, 
  • Glycerin
  • Hydrochloric acid (for pH adjustment), 
  • Orange flavor
  • Sodium benzoate
  • Sucralose
  • Water and xanthan gum

Key Benefits

  • Reduces inflammation in muscles, which is beneficial in conditions like Duchenne muscular dystrophy.
  • Designed to minimize common side effects associated with traditional corticosteroids, such as bone loss, growth retardation, and immune suppression.
  • Aimed at preserving muscle strength and function in DMD patients, potentially slowing disease progression.

Direction For Use

  • AMAGREE (vamorolone) taken 6mg orally once daily with meal.
  • Some people taken 2mg daily.

Safety Concern

  • Bone Health: Potential for bone density reduction with prolonged use.
  • Growth and Development: Effects on growth and development in children and adolescents.
  • Immune Function: Monitoring immune function due to potential immunosuppressive effects.

Avoid Taking AMAGREE (vamorolone) If:

  • You have had an allergic reaction to vamorolone or any of its components.
  • You have active infections or certain medical conditions where immunosuppression could exacerbate the condition.

The product may appear different from
the product illustrated here



Image Image Image Image